Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Beneficial Effects of Capsaicin in Disorders of the Central Nervous System

Pasierski M, Szulczyk B.

Molecules. 2022 Apr 12;27(8):2484. doi: 10.3390/molecules27082484.

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A

Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X.

J Neuroinflammation. 2022 Apr 22;19(1):98. doi: 10.1186/s12974-022-02446-6.

Sporadic adult-onset neuronal intranuclear inclusion disease without high-intensity signal on DWI and T2WI: a case report

Wang H, Feng F, Liu J, Deng J, Bai J, Zhang W, Wang L, Xu B, Huang X.

BMC Neurol. 2022 Apr 22;22(1):150. doi: 10.1186/s12883-022-02673-7.

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson's disease

Chalazonitis A, Rao M, Sulzer D.

NPJ Parkinsons Dis. 2022 Apr 22;8(1):50. doi: 10.1038/s41531-022-00308-9.

From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview

Rausch WD, Wang F, Radad K.

J Neural Transm (Vienna). 2022 Jun;129(5-6):487-495. doi: 10.1007/s00702-022-02488-3. Epub 2022 Apr 23.

Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease

Yu QY, Ye LQ, Li HL.

Neurochem Int. 2022 Jul;157:105342. doi: 10.1016/j.neuint.2022.105342. Epub 2022 Apr 21.

Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification

Zhong Z, He X, Ge J, Zhu J, Yao C, Cai H, Ye XY, Xie T, Bai R.

Eur J Med Chem. 2022 Jul 5;237:114378. doi: 10.1016/j.ejmech.2022.114378. Epub 2022 Apr 18.

Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials

Fujikawa J, Morigaki R, Yamamoto N, Oda T, Nakanishi H, Izumi Y, Takagi Y.

Front Aging Neurosci. 2022 Mar 29;14:807909. doi: 10.3389/fnagi.2022.807909. eCollection 2022.

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence

Bandopadhyay R, Mishra N, Rana R, Kaur G, Ghoneim MM, Alshehri S, Mustafa G, Ahmad J, Alhakamy NA, Mishra A.

Front Pharmacol. 2022 Apr 7;13:805388. doi: 10.3389/fphar.2022.805388. eCollection 2022.

Gastrodin and Vascular Dementia: Advances and Current Perspectives

Deng C, Chen H, Meng Z, Meng S.

Evid Based Complement Alternat Med. 2022 Apr 12;2022:2563934. doi: 10.1155/2022/2563934. eCollection 2022.

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease

Li S, Le W, Deng H.

Front Neurosci. 2022 Apr 6;16:842709. doi: 10.3389/fnins.2022.842709. eCollection 2022.

Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging

Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, Chen S, Lin X, Zhang G, Xiao H, Dong B.

Front Immunol. 2022 Apr 7;13:796288. doi: 10.3389/fimmu.2022.796288. eCollection 2022.

Mitochondrial quality control in health and in Parkinson's disease

Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA.

Physiol Rev. 2022 Oct 1;102(4):1721-1755. doi: 10.1152/physrev.00041.2021. Epub 2022 Apr 25.

Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions

Isaacson SH, Citrome L.

Expert Opin Drug Saf. 2022 Jul;21(7):873-879. doi: 10.1080/14740338.2022.2069240. Epub 2022 May 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias